The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

In this episode of the Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, ...

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European ...

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

The following six biosimilars were given a positive opinion at the June meeting: treatments for treatment of age-related macular degeneration and visual impairment: Mynzepli (aflibercept), and its ...

BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. as part ...

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...

Fabian Gerlinghaus, Alexander Seyf, and Knut Steffensen go behind the headlines and dive into the advanced therapy ecosystem.

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...